Interleukin-6 is a direct mediator of T cell migration

被引:92
作者
Weissenbach, M
Clahsen, T
Weber, C
Spitzer, D
Wirth, D
Vestweber, D
Heinrich, PC
Schaper, F
机构
[1] Rhein Westfal TH Aachen, Dept Biochem, Sch Med, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Dept Mol Cardiol, D-5100 Aachen, Germany
[3] Gesell Biotechnol Forsch mbH, Dept Mol Biotechnol, D-3300 Braunschweig, Germany
[4] Univ Munster, Max Planck Inst Munster, D-4400 Munster, Germany
[5] Univ Munster, Inst Cell Biol, ZMBE, D-4400 Munster, Germany
关键词
cytokines; inflammation; chemotaxis; signal transduction; molecular biology;
D O I
10.1002/eji.200425237
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-6 is a pleiotropic cytokine involved in the differentiation and proliferation of hematopoietic cells. Hepatocytes respond to IL-6 with the synthesis and secretion of acute-phase proteins. In addition, IL-6 plays a role as a migration factor in vivo. In the present paper, we studied the potential of IL-6 to mediate migration of human primary T cells and T cell-derived cell lines. IL-6 was found to induce migration only in the presence of extracellular matrix, suggesting a cross-talk between the IL-6- and integrin signal transduction pathways. Furthermore, an IL-6 gradient is required for chemotactic migration. This activity is not due to the release of secondary chemotactic activities, but is a direct response to IL-6. T cell migration could also be observed in response to IL-11, but no migration was found after stimulation with leukemia inhibitory factor or oncostatin M, although these cytokines signal through gp130-containing receptor complexes. Finally, we present evidence that activation of the mitogen-activated protein kinase (MAPK) cascade, the phosphatidylinositol 3-kinase as well as the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is crucial for IL-6-induced migration. Selective activation of the JAK/STAT or the MAPK cascade by mutated receptor proteins shows a crucial role of IL-6-initiated SH2 domain-containing tyrosine phosphatase 2/MAPK activity for migration.
引用
收藏
页码:2895 / 2906
页数:12
相关论文
共 32 条
[1]  
BACON K, 1990, Cytokine, V2, P100, DOI 10.1016/1043-4666(90)90003-C
[2]  
Badache A, 2001, CANCER RES, V61, P383
[3]   Chemoattractive effect on the effector cells of the supernatants from melanoma cells transfected with the interleukin-2 (IL-2), IL-4 or IL-6 gene [J].
Cao, XT ;
Chen, GY ;
He, L ;
Zhang, WP ;
Yu, YZ ;
Ye, TX .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (02) :88-92
[4]   TUMOR-DERIVED TRANSFORMING GROWTH-FACTOR-BETA-1 AND INTERLEUKIN-6 ARE CHEMOTACTIC FOR LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DELENS, N ;
TORREELE, E ;
SAVELKOOL, H ;
DEBAETSELIER, P ;
BOUWENS, L .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) :696-700
[5]  
Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO
[6]  
2-D
[7]   Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis [J].
Fukada, T ;
Hibi, M ;
Yamanaka, Y ;
TakahashiTezuka, M ;
Fujitani, Y ;
Yamaguchi, T ;
Nakajima, K ;
Hirano, T .
IMMUNITY, 1996, 5 (05) :449-460
[8]   Complexity and specificity of integrin signalling [J].
Giancotti, FG .
NATURE CELL BIOLOGY, 2000, 2 (01) :E13-E14
[9]   Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway [J].
Heinrich, PC ;
Behrmann, I ;
Müller-Newen, G ;
Schaper, F ;
Graeve, L .
BIOCHEMICAL JOURNAL, 1998, 334 :297-314
[10]   Principles of interleukin (IL)-6-type cytokine signalling and its regulation [J].
Heinrich, PC ;
Behrmann, I ;
Haan, S ;
Hermanns, HM ;
Müller-Newen, G ;
Schaper, F .
BIOCHEMICAL JOURNAL, 2003, 374 (01) :1-20